Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival

Intermittent parathyroid hormone fails to stimulate osseointegration in diabetic rats

(2011) Ulrike Kuchler et al.   CLINICAL ORAL IMPLANTS RESEARCH

Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism

(2010) Mathieu Ferron et al.   CELL

Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats

(2010) Chung-Ching Liu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone

(2010) Chung C. Liu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms

(2010) Robert L Jilka et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The bone marrow microenvironment contributes to type I diabetes induced osteoblast death

(2010) Lindsay M. Coe et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Streptozotocin, Type I Diabetes Severity and Bone

(2009) Katherine Motyl et al.   BIOLOGICAL PROCEDURES ONLINE

Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair

(2009) Matthew Schnoke et al.   BONE

Role of Parathyroid Hormone-Related Protein in the Decreased Osteoblast Function in Diabetes-Related Osteopenia

(2009) Daniel Lozano et al.   ENDOCRINOLOGY

Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent parathyroid hormone treatment

(2009) P.J. Niziolek et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation

(2008) Glenda J. Pettway et al.   BONE

Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts

(2008) Robert L. Jilka et al.   BONE

Differentiation and Proliferation of Periosteal Osteoblast Progenitors Are Differentially Regulated by Estrogens and Intermittent Parathyroid Hormone Administration

(2008) Mami Ogita et al.   ENDOCRINOLOGY

An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?

(2008) Ernest Beng Kee Kwek et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

Stimulation of Fracture-Healing with Systemic Intermittent Parathyroid Hormone Treatment

(2008) George L. Barnes et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study

(2008) Bo Abrahamsen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice

(2008) Katherine J. Motyl et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Bone inflammation and altered gene expression with type I diabetes early onset

(2008) Katherine J. Motyl et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Low-Energy Femoral Shaft Fractures Associated With Alendronate Use

(2008) Andrew S Neviaser et al.   JOURNAL OF ORTHOPAEDIC TRAUMA

Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate

(2008) Brett A. Lenart et al.   NEW ENGLAND JOURNAL OF MEDICINE

Runt-Related Transcription Factor 2 (RUNX2) and RUNX2-Related Osteogenic Genes Are Down-Regulated throughout Osteogenesis in Type 1 Diabetes Mellitus

(2007) John L. Fowlkes et al.   ENDOCRINOLOGY